The real per capita spending on healthcare in Singapore was forecast to continuously increase between 2024 and 2029 by in total ***** U.S. dollars (+***** percent). After the ***** consecutive increasing year, the real healthcare-related per capita spending is estimated to reach ******** U.S. dollars and therefore a new peak in 2029. Consumer spending, in this case healthcare-related spending per capita, refers to the domestic demand of private households and non-profit institutions serving households (NPISHs). Spending by corporations and the state is not included. The forecast has been adjusted for the expected impact of COVID-19.Consumer spending is the biggest component of the gross domestic product as computed on an expenditure basis in the context of national accounts. The other components in this approach are consumption expenditure of the state, gross domestic investment as well as the net exports of goods and services. Consumer spending is broken down according to the United Nations' Classification of Individual Consumption By Purpose (COICOP). The shown data adheres broadly to group **. As not all countries and regions report data in a harmonized way, all data shown here has been processed by Statista to allow the greatest level of comparability possible. The underlying input data are usually household budget surveys conducted by government agencies that track spending of selected households over a given period.The data has been converted from local currencies to US$ using the average constant exchange rate of the base year 2017. The timelines therefore do not incorporate currency effects. The data is shown in real terms which means that monetary data is valued at constant prices of a given base year (in this case: 2017). To attain constant prices the nominal forecast has been deflated with the projected consumer price index for the respective category.Find more key insights for the real per capita spending on healthcare in countries like Vietnam and Myanmar.

In financial year 2025, the health expenditure as a share of the gross domestic product (GDP) in Singapore was estimated to reach 2.7 percent. Healthcare spending as share of the GDP had increased in Singapore since 2016 due to a myriad of factors, including improving infrastructure and increasing spending to meet the healthcare demands of an aging population.

Dataset from Singapore Department of Statistics. For more information, visit https://data.gov.sg/datasets/d_a40c83a6f36893fc4611eda91f84eb6b/view

In 2022, the Singapore government spent approximately 3,770 current international dollars at purchasing power parity (PPP) per resident on health. The marked increase in spending between 2019 and 2020 was due to the COVID-19 pandemic.

Historical dataset showing Singapore healthcare spending per capita by year from 2000 to 2022.

Singapore SG: Current Health Expenditure Per Capita: Current Price data was reported at 0.002 USD mn in 2015. This records an increase from the previous number of 0.002 USD mn for 2014. Singapore SG: Current Health Expenditure Per Capita: Current Price data is updated yearly, averaging 0.001 USD mn from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 0.002 USD mn in 2015 and a record low of 0.001 USD mn in 2001. Singapore SG: Current Health Expenditure Per Capita: Current Price data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Singapore – Table SG.World Bank.WDI: Health Statistics. Current expenditures on health per capita in current US dollars. Estimates of current health expenditures include healthcare goods and services consumed during each year.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

Dataset from Ministry of Health. For more information, visit https://data.gov.sg/datasets/d_59f95bfb94f977cc3d9e74ac6f156ab5/view

Singapore SG: Out-of-Pocket Health Expenditure: % of Current Health Expenditure data was reported at 36.737 % in 2015. This records a decrease from the previous number of 38.151 % for 2014. Singapore SG: Out-of-Pocket Health Expenditure: % of Current Health Expenditure data is updated yearly, averaging 48.318 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 55.590 % in 2001 and a record low of 36.737 % in 2015. Singapore SG: Out-of-Pocket Health Expenditure: % of Current Health Expenditure data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Singapore – Table SG.World Bank.WDI: Health Statistics. Share of out-of-pocket payments of total current health expenditures. Out-of-pocket payments are spending on health directly out-of-pocket by households.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

Singapore SG: Domestic Private Health Expenditure: % of Current Health Expenditure data was reported at 48.124 % in 2015. This records a decrease from the previous number of 49.048 % for 2014. Singapore SG: Domestic Private Health Expenditure: % of Current Health Expenditure data is updated yearly, averaging 62.810 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 72.115 % in 2001 and a record low of 48.124 % in 2015. Singapore SG: Domestic Private Health Expenditure: % of Current Health Expenditure data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Singapore – Table SG.World Bank.WDI: Health Statistics. Share of current health expenditures funded from domestic private sources. Domestic private sources include funds from households, corporations and non-profit organizations. Such expenditures can be either prepaid to voluntary health insurance or paid directly to healthcare providers.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

Singapore SG: Current Health Expenditure: % of GDP data was reported at 4.252 % in 2015. This records an increase from the previous number of 3.927 % for 2014. Singapore SG: Current Health Expenditure: % of GDP data is updated yearly, averaging 3.289 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 4.252 % in 2015 and a record low of 2.853 % in 2007. Singapore SG: Current Health Expenditure: % of GDP data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Singapore – Table SG.World Bank.WDI: Health Statistics. Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

Health expenditure as a share of GDP of Singapore dropped by 5.22% from 5.2 % in 2021 to 4.9 % in 2022. Since the 29.02% jump in 2020, health expenditure as a share of GDP slumped by 12.80% in 2022. Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.

In 2021, Singapore had the highest per capita health spending among countries in Southeast Asia, at around 3,970 U.S. dollars. Brunei followed with the health expenditure per capita of around ****** U.S. dollars of that year.

Singapore SG: Domestic General Government Health Expenditure: % of Current Health Expenditure data was reported at 51.876 % in 2015. This records an increase from the previous number of 50.952 % for 2014. Singapore SG: Domestic General Government Health Expenditure: % of Current Health Expenditure data is updated yearly, averaging 37.190 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 51.876 % in 2015 and a record low of 27.885 % in 2001. Singapore SG: Domestic General Government Health Expenditure: % of Current Health Expenditure data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Singapore – Table SG.World Bank.WDI: Health Statistics. Share of current health expenditures funded from domestic public sources for health. Domestic public sources include domestic revenue as internal transfers and grants, transfers, subsidies to voluntary health insurance beneficiaries, non-profit institutions serving households (NPISH) or enterprise financing schemes as well as compulsory prepayment and social health insurance contributions. They do not include external resources spent by governments on health.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

Among OECD member countries, the United States had the ******* percentage of gross domestic product spent on health care as of 2024. The U.S. spent nearly **** percent of its GDP on health care services. Germany, Austria, and Germany followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries. Why compare OECD countries? OECD stands for Organization for Economic Co-operation and Development. It is an economic organization consisting of 38 members, mostly high-income countries and committed to democratic principles and market economy. This makes OECD statistics more comparable than statistics of developed and undeveloped countries. Health economics is an important matter for the OECD, even more since increasing health costs and an aging population have become an issue for many developed countries. Health costs in the U.S. A higher GDP share spent on health care does not automatically lead to a better functioning health system. In the case of the U.S., high spending is mainly because of higher costs and prices, not due to higher utilization. For example, physicians’ salaries are much higher in the U.S. than in other comparable countries. A doctor in the U.S. earns more than ***** as much as the average physician in Germany. Pharmaceutical spending per capita is also distinctly higher in the United States. Furthermore, the U.S. also spends more on health administrative costs compared to other wealthy countries.

Singapore Digital Health Insurance Market is valued at USD 6.5 billion, driven by telemedicine, AI, rising healthcare costs, and government initiatives for digital health solutions.

Singapore SG: Proportion of Population Spending More Than 10% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure: % data was reported at 9.014 % in 2012. Singapore SG: Proportion of Population Spending More Than 10% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure: % data is updated yearly, averaging 9.014 % from Dec 2012 (Median) to 2012, with 1 observations. Singapore SG: Proportion of Population Spending More Than 10% of Household Consumption or Income on Out-of-Pocket Health Care Expenditure: % data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Singapore – Table SG.World Bank.WDI: Poverty. Proportion of population spending more than 10% of household consumption or income on out-of-pocket health care expenditure.; ; World Health Organization and World Bank. 2019. Global Monitoring Report on Financial Protection in Health 2019.; Weighted average;

The current healthcare spending per capita in Vietnam was forecast to continuously increase between 2024 and 2029 by in total ** U.S. dollars (+**** percent). After the ninth consecutive increasing year, the spending is estimated to reach ****** U.S. dollars and therefore a new peak in 2029. Depicted here is the average per capita spending, in a given country or region, with regards to healthcare. The spending refers to the average current spending of both governments and consumers per inhabitant.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to *** countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the current healthcare spending per capita in countries like Singapore and Philippines.

Private Healthcare Market Outlook

In 2023, the global private healthcare market size was valued at USD 1.3 trillion, and it is projected to grow at a robust CAGR of 6.8% from 2024 to 2032, reaching a forecasted value of USD 2.34 trillion by 2032. This significant growth is driven by the increasing demand for quality healthcare services, especially in developing economies, coupled with a growing preference for personalized and private medical care.

The rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer has been a substantial growth factor for the private healthcare market. With the increasing burden of these diseases, there is a heightened need for advanced medical treatments and continuous monitoring, which private healthcare facilities are well-equipped to provide. Additionally, the aging global population is contributing to an elevated demand for healthcare services, as older adults typically require more medical attention, specialized treatments, and long-term care solutions.

Technological advancements in the healthcare sector are another pivotal growth driver. Innovations such as telemedicine, AI-driven diagnostics, robotic surgeries, and personalized medicine have revolutionized the healthcare landscape, enhancing the quality and efficiency of care. These advancements not only improve patient outcomes but also increase the attractiveness of private healthcare services, as they often provide quicker access to the latest medical technologies and treatments compared to public health systems.

Moreover, the increase in disposable incomes and the growing middle-class population in emerging markets are significant contributors to the market's growth. As more individuals can afford private healthcare services, there is a rising trend of opting for private health insurance plans that cover a range of medical expenses. This shift is further supported by the fact that private healthcare services often offer reduced waiting times, personalized care, and better facilities, making them a preferred choice for many.

Healthcare Tourism is emerging as a significant trend within the private healthcare sector, driven by the increasing number of patients seeking high-quality medical treatments abroad. This trend is particularly prominent in countries like India, Thailand, and Singapore, where private healthcare providers offer advanced medical procedures at competitive prices. The appeal of healthcare tourism lies in its ability to combine medical care with travel, allowing patients to receive treatments while exploring new destinations. As global connectivity improves and the demand for cost-effective healthcare solutions rises, healthcare tourism is expected to contribute substantially to the growth of the private healthcare market.

Regionally, North America holds the largest share of the private healthcare market, driven by high healthcare expenditure, advanced infrastructure, and a well-established insurance system. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period, attributed to rapid economic development, increasing healthcare investments, and a significant population base. Europe also remains a significant market due to its high-quality healthcare services and favorable reimbursement policies.

Service Type Analysis

The private healthcare market by service type is broadly categorized into inpatient services, outpatient services, diagnostic services, wellness services, and others. Inpatient services, which include hospitalization and surgical procedures, form a substantial segment due to the comprehensive care required for severe and chronic conditions. The rising prevalence of such conditions has led to a higher demand for inpatient care, making it a crucial component of private healthcare facilities.

Outpatient services are also a critical segment, encompassing a wide range of medical services such as consultations, minor surgical procedures, and follow-up visits that do not require hospital admission. The convenience and cost-effectiveness of outpatient care have made it increasingly popular among patients, driving significant growth in this segment. The development of advanced outpatient care centers equipped with modern diagnostic and treatment facilities further boosts this trend.

Diagnostic services, including laboratory tests, imaging, and other diagnostic procedur

The APAC healthcare IT market is booming, projected to reach [estimated 2033 market size in millions] by 2033 with an 8.50% CAGR. Discover key drivers, trends, and challenges shaping this dynamic sector, including EHR adoption, telehealth expansion, and the role of major players like IBM and McKesson. Recent developments include: August 2022: Intellect, Asia Pacific's mental health technology company, declared its official launch in Japan as part of its regional expansion plans. Intellect's launch in Japan is heavily backed by some of Japan's most prominent venture capital investors, including JAFCO Asia, Headline Asia, DG Daiwa Ventures, and some of the largest Japanese conglomerates, PERSOL Holdings, and MS&AD Ventures., February 2022: The Indian government announced two new projects to promote digital health for its citizens as it continues to battle the ongoing COVID-19 pandemic. The government would launch an open platform connecting the country's digital health ecosystem under the Ayushman Bharat Digital Health Mission (ABDM). The platform would include digital registries of health providers and facilities, unique health identities, a consent framework, and universal access to health facilities.. Key drivers for this market are: Supportive government policies and introduction of FDI in major countries to aid adoption, Growing pressure on the healthcare infrastructure in the region due to high population coupled with the need to reduce expenditure; Emergence of Singapore and other SEA countries as a hub in medical IT sector backed by the strong investment activity and higher propensity to adopt digital transformation practices5.1.4 key global cues such as patient-based & on-demand healthcare delivery & continuous monitoring expected to drive adoption in Asia; Early adopters such as Japan and China continue to record steady growth due to demographic and economic conditions. Potential restraints include: High Costs and Operational Concerns, Concerns related to Geoprivacy and Confidential Data. Notable trends are: Patient Based Systems (Remote Healthcare, Wearables etc.) is Expected to Hold the Largest Market Share.